Updated on 2026/03/11

写真a

 
TANAKA Chie
 
Organization
Nagoya University Hospital Department of Medical Devices Associate Professor of Hospital
Title
Associate Professor of Hospital

Degree 1

  1. 博士(医学) ( 2010.3   名古屋大学 ) 

Research Areas 1

  1. Life Science / Digestive surgery

Research History 2

  1. 名古屋大学医学部附属病院消化器外科二講師

    2021.4

  2. 名古屋大学医学部附属病院消化器外科二病院講師

    2018.4 - 2021.3

      More details

    Country:Japan

Education 1

  1. Nagoya University   Graduate School, Division of Medical Sciences

    - 2010.3

      More details

    Country: Japan

Professional Memberships 10

  1. 日本外科学会

  2. 日本消化器外科学会

  3. 日本胃癌学会

  4. 日本内視鏡外科学会

  5. 日本ロボット外科学会

  6. 日本肥満症治療学会

  7. 日本大腸肛門病学会

  8. 日本癌学会

  9. 日本癌治療学会

  10. 日本臨床外科学会

▼display all

Committee Memberships 4

  1. 日本消化器外科学会   学術委員会委員  

    2021.9   

      More details

    Committee type:Academic society

  2. 日本消化器外科学会   男女共同参画ワーキンググループ委員  

    2021.9   

      More details

    Committee type:Academic society

  3. 日本消化器外科学会   試験問題作成委員会委員(胃十二指腸)  

    2021.9   

      More details

    Committee type:Academic society

  4. 日本消化器外科学会   データベース委員会委員  

    2021.9   

      More details

    Committee type:Academic society

Awards 3

  1. 日本内視鏡外科学会 ePoster Award

    2017.12   日本内視鏡外科学会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  2. 日本癌治療学会 優秀演題賞

    2008   日本癌治療学会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  3. 優秀演題賞

    日本ロボット外科学会   胃癌におけるアプローチ別の胃切除術後の治療成績についての検討

 

Papers 237

  1. Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study

    Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y.

    Asian Journal of Endoscopic Surgery   Vol. 13 ( 2 ) page: 160-167   2020.4

     More details

    Authorship:Lead author, Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/ases.12710. 

  2. Overexpression of cat eye syndrome chromosome region, candidate 2 in esophageal squamous carcinoma cell promotes tumor aggressiveness by facilitating NF-κB signaling and inhibition of p53-associated apoptosis

    Zhu, HT; Kanda, M; Shimizu, D; Sato, Y; Bayasgalan, T; Hamrah, MH; Martinez, FEG; Shinozuka, T; Aoki, K; Umeda, S; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    CLINICAL & TRANSLATIONAL ONCOLOGY   Vol. 28 ( 2 ) page: 575 - 588   2026.2

     More details

  3. Annual Report of the 2022 National Clinical Database: Decade-Long Trends and Current Status of Gastroenterological Surgery in Japan

    Kumagai, K; Takahashi, A; Ueno, H; Hiki, N; Kajiwara, Y; Ebata, T; Otsuka, T; Oshikiri, T; Kakeji, Y; Goi, T; Saiura, A; Saeki, H; Tanaka, C; Tokunaga, M; Fujii, T; Matsuda, S; Mizushima, T; Yamamoto, H; Kitagawa, Y; Shirabe, K

    ANNALS OF GASTROENTEROLOGICAL SURGERY     2026.1

  4. Trends in Gender Disparities in Surgical Experience: A National Clinical Database Study

    Tanaka, C; Yamamoto, H; Nomura, S; Kono, E; Ueno, H; Kakeji, Y; Shirabe, K

    ANNALS OF GASTROENTEROLOGICAL SURGERY   Vol. 10 ( 1 ) page: 263 - 274   2026.1

     More details

  5. Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo)

    Hattori, N; Nakayama, G; Umeda, S; Kishida, T; Takeda, S; Ezaka, K; Tsutsuyama, M; Sakai, M; Hattori, M; Ito, T; Kanda, M; Tanaka, C; Murotani, K; Ando, M; Kodera, Y

    JAPANESE JOURNAL OF CLINICAL ONCOLOGY     2025.12

     More details

  6. Surgery for Older Cancer Patients: Cross-Organ Review and Good Practice Statement by the Japanese Geriatric Oncology Guideline Committee

    Tanaka, C; Ofuchi, T; Ninomiya, K; Inoue, D; Sugimoto, K; Murofushi, K; Okuyama, T; Watanuki, S; Imamura, C; Sakai, D; Sakurai, N; Watanabe, K; Tamura, K; Saeki, T; Ishiguro, H

    ANNALS OF GASTROENTEROLOGICAL SURGERY   Vol. 9 ( 6 ) page: 1128 - 1136   2025.11

     More details

  7. The role of CST2 in the pathogenesis and prognosis of esophageal squamous cell carcinoma

    Martinez, FEG; Kanda, M; Sato, Y; Zhu, HT; Bayasgalan, T; Hamrah, MH; Shimizu, D; Tanaka, H; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    CLINICAL & TRANSLATIONAL ONCOLOGY   Vol. 27 ( 10 ) page: 3981 - 3992   2025.10

     More details

  8. Primary endpoint analysis of phase II interventional trial evaluating the efficacy and safety of neoadjuvant docetaxel, oxaliplatin plus S-1 for locally advanced squamous cell carcinoma of the esophagus (CCOG2102)

    Shimizu, D; Iizuka, A; Kishida, T; Nakagawa, N; Kurimoto, K; Tanaka, H; Umeda, S; Nakanishi, K; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kanda, M

    ANNALS OF ONCOLOGY   Vol. 36   2025.9

  9. Cholinergic Receptor Nicotinic Beta 2 Subunit Promotes the Peritoneal Disseminating Metastasis of Colorectal Cancer

    Umeda, S; Tanaka, K; Kishida, T; Hattori, N; Tanaka, H; Shimizu, D; Takami, H; Hayashi, M; Tanaka, C; Nakayama, G; Kanda, M

    CANCERS   Vol. 17 ( 15 )   2025.7

     More details

  10. Long-term quality of life after distal and pylorus-preserving gastrectomy for stage I gastric cancer: A prospective multi-institutional study (CCOG1601)

    Tanaka, C; Kanda, M; Misawa, K; Mochizuki, Y; Watanabe, T; Hattori, M; Murotani, K; Kodera, Y

    ANNALS OF ONCOLOGY   Vol. 36   2025.7

  11. Efficacy and safety of postoperative adjuvant chemotherapy with oxaliplatin for elderly patients: results from the CCOG-1302 study

    Umeda, S; Nakayama, G; Kishida, T; Hattori, N; Nakanishi, K; Tanaka, H; Shimizu, D; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kodera, Y

    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 30 ( 6 ) page: 1174 - 1182   2025.6

     More details

  12. Association of NR0B1 with Malignant Phenotypes in Esophageal Squamous Cell Carcinoma Through Modulation of p53-Independent Cell-Cycle Regulation

    Iizuka, A; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Tanaka, H; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 32 ( 6 ) page: 4464 - 4475   2025.6

     More details

  13. High Expression of OR1F1 Protein as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma

    Yamagishi, S; Kanda, M; Shinozuka, T; Sato, Y; Shimizu, D; Tanaka, C; Umeda, S; Tanaka, H; Takami, H; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y; Okamura, Y

    ANTICANCER RESEARCH   Vol. 45 ( 5 ) page: 1997 - 2009   2025.5

     More details

  14. Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer Patients

    Nakagawa, N; Hayashi, M; Kobayashi, D; Otsu, T; Sonohara, F; Kurimoto, K; Tanaka, H; Inokawa, Y; Takami, H; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANTICANCER RESEARCH   Vol. 45 ( 4 ) page: 1343 - 1353   2025.4

     More details

  15. <i>SPOCD1 </i>Enhances Cancer Cell Activities and Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma

    Bayasgalan, T; Kanda, M; Sato, Y; Zhu, HT; Hamrah, MH; Martinez, FEG; Shinozuka, T; Ito, Y; Sasahara, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    CANCER GENOMICS & PROTEOMICS   Vol. 22 ( 2 ) page: 306 - 325   2025.3

     More details

  16. The long-term quality of life after distal and pylorus-preserving gastrectomy for stage I gastric cancer: A prospective multi-institutional study (CCOG1601)

    Tanaka, C; Kanda, M; Misawa, K; Mochizuki, Y; Watanabe, T; Hattori, M; Ishigure, K; Sueoka, S; Teramoto, H; Ishiyama, A; Nonogaki, I; Matsushita, H; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 55 ( 2 ) page: 162 - 171   2025.2

     More details

  17. Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (RINDO study).

    Hattori, M; Hattori, N; Nakayama, G; Umeda, S; Kishida, T; Kawase, Y; Ezaka, K; Tsutsuyama, M; Sakai, M; Ito, T; Yanbe, Y; Kanda, M; Tanaka, C; Murotani, K; Ando, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 43 ( 4_SUPPL ) page: 124 - 124   2025.2

  18. Metastatic pattern specific biomarkers of gastric cancer; toward drug discovery

    Kanda, M; Tanaka, C; Dai, SMZ; Hayashi, M; Nakayama, G; Kodera, Y

    CANCER SCIENCE   Vol. 116   page: 776 - 776   2025.1

     More details

  19. <i>FAM32A</i> Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer

    Agatsuma, Y; Shimizu, D; Umeda, S; Tanaka, H; Hattori, N; Hayashi, M; Kanda, M; Tanaka, C; Nakayama, G; Fujiwara, M; Kodera, Y

    CANCER GENOMICS & PROTEOMICS   Vol. 22 ( 1 ) page: 55 - 69   2025.1

     More details

  20. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan

    Ito, S; Takahashi, A; Ueno, H; Takiguchi, S; Kajiwara, Y; Kakeji, Y; Eguchi, S; Goi, T; Saiura, A; Sasaki, A; Takeuchi, H; Tanaka, C; Hashimoto, M; Hiki, N; Horiguchi, A; Matsuda, S; Mizushima, T; Yamamoto, H; Kitagawa, Y; Shirabe, K

    ANNALS OF GASTROENTEROLOGICAL SURGERY   Vol. 9 ( 1 ) page: 32 - 59   2025.1

     More details

  21. Oncological similarities between large type 3 and type 4 tumors in patients with resectable gastric cancer: a propensity score-matched analysis of a multi-institutional dataset

    Nakanishi, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Shimizu, D; Tanaka, C; Fujiwara, M; Murotani, K; Kodera, Y

    GASTRIC CANCER   Vol. 27 ( 6 ) page: 1331 - 1341   2024.11

     More details

  22. Long-term quality of life after open and laparoscopic total gastrectomy for stage I gastric cancer: A prospective multi-institutional study (CCOG1504)

    Tanaka, C; Kanda, M; Misawa, K; Mochizuki, Y; Hattori, M; Sueoka, S; Watanabe, T; Yamada, T; Murotani, K; Kodera, Y

    ANNALS OF GASTROENTEROLOGICAL SURGERY   Vol. 8 ( 6 ) page: 999 - 1007   2024.11

     More details

  23. Genome-wide microRNA Analysis Identified<i> miR-210-3p</i> Over-expression in Pancreatic Cancer Tissues as a Predictor of their Local Invasiveness

    Otsu, T; Hayashi, M; Fujita, K; Kobayashi, D; Nakagawa, N; Kurimoto, K; Takami, H; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANTICANCER RESEARCH   Vol. 44 ( 11 ) page: 4709 - 4721   2024.11

     More details

  24. A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy

    Liang, Y; Maeda, O; Miyata, K; Tanaka, C; Kanda, M; Shimizu, D; Fukaya, M; Koike, M; Kodera, Y; Ando, Y

    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY   Vol. 20 ( 5 ) page: 661 - 667   2024.10

     More details

  25. Expression profile and function of secretogranin V, and its effects on the malignant behavior of esophageal squamous cell carcinoma

    Hamrah, MH; Kanda, M; Sato, Y; Zhu, HT; Bayasgalan, T; Garza, F; Shinozuka, T; Ito, Y; Sasahara, M; Shimizu, D; Umeda, S; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    DISEASES OF THE ESOPHAGUS   Vol. 37 ( 12 )   2024.9

     More details

  26. Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma

    Shinozuka, T; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 31 ( 9 ) page: 5674 - 5682   2024.9

     More details

  27. ASO Visual Abstract: Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma

    Shinozuka, T; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 31 ( 9 ) page: 5776 - 5777   2024.9

  28. Seasonal and Annual Rainfall Patterns Modify Summer Energy Balance and Nutritional Condition of Grazing Sheep Via Vegetation Communities

    Yoshihara, Y; Tanaka, C; Choijilsuren, B; Tserendorj, J; Byambajav, B; Umemura, K; Kinugasa, T; Shinoda, M

    RANGELAND ECOLOGY & MANAGEMENT   Vol. 95   page: 77 - 83   2024.7

  29. Prognostic Impact of <i>CDKN2A</i> Mutations Associated With Smoking and Drinking History in Japanese Digestive Cancers

    Fujita, K; Hayashi, M; Nakagawa, N; Kurimoto, K; Inokawa, Y; Takami, H; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANTICANCER RESEARCH   Vol. 44 ( 6 ) page: 2699 - 2707   2024.6

     More details

  30. Long-term quality of life after open and laparoscopic total gastrectomy for stage I gastric cancer: A prospective multiinstitutional study (CCOG1504)

    Tanaka, C; Kanda, M; Kodera, Y

    ANNALS OF ONCOLOGY   Vol. 35   page: S174 - S174   2024.6

  31. Outcomes of surgical treatment for enterovesical fistula in Crohn's disease

    Hattori, N; Nakayama, G; Umeda, S; Nakamura, M; Yamamura, T; Sawada, T; Nakanishi, K; Shimizu, D; Kanda, M; Hayashi, M; Tanaka, C; Kodera, Y

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 86 ( 2 ) page: 280 - 291   2024.5

     More details

  32. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways

    Ito, Y; Kanda, M; Sasahara, M; Tanaka, C; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

    GASTRIC CANCER   Vol. 27 ( 3 ) page: 506 - 518   2024.5

     More details

  33. Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

    Sugiyama, F; Kanda, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 31 ( 5 ) page: 3417 - 3425   2024.5

     More details

  34. ASO Visual Abstract: Absence of Hypercoagulation Status After Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

    Sugiyama, F; Kanda, M; Shimizu, D; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 31 ( 5 ) page: 3477 - 3478   2024.5

  35. Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth <i>via</i> BCL-2-mediated intrinsic apoptosis

    Sasahara, M; Kanda, M; Tanaka, C; Shimizu, D; Umeda, S; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

    INTERNATIONAL JOURNAL OF CANCER   Vol. 154 ( 7 ) page: 1272 - 1284   2024.4

     More details

  36. Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy: A Retrospective Analysis

    Agatsuma, Y; Nakanishi, K; Tanaka, C; Kanda, M; Shimizu, D; Umeda, S; Kurimoto, K; Inokawa, Y; Takami, H; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 44 ( 4 ) page: 1645 - 1651   2024.4

     More details

  37. A multi-institutional prospective observational study to compare postoperative quality of life of patients who undergo total or proximal gastrectomy for early gastric cancer (CCOG1602)

    Kanda, M; Tanaka, C; Misawa, K; Mochizuki, Y; Watanabe, T; Sueoka, S; Ishiyama, A; Yamada, T; Oshima, T; Hattori, M; Koike, S; Ishigure, K; Teramoto, H; Murotani, K; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 48 ( 3 ) page: 681 - 691   2024.3

     More details

  38. Gender equity in surgical instruments: ergonomics of ring-handled forceps

    Kono, E; Nomura, S; Sakamoto, T; Okoshi, K; Tanaka, C; Shirabe, K; Lee, SW; Kitagawa, Y

    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES   Vol. 33 ( 1 ) page: 21 - 28   2024.2

     More details

  39. Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer

    Nakanishi, K; Tanaka, C; Kanda, M; Miyata, K; Machida, N; Sakai, M; Kobayashi, D; Teramoto, H; Ishiyama, A; Sato, B; Oshima, T; Kajikawa, M; Matsushita, H; Ishigure, K; Yamashita, K; Fujitake, S; Sueoka, S; Asada, T; Shimizu, D; Sugita, S; Kuwatsuka, Y; Maeda, O; Furune, S; Murotani, K; Ando, Y; Ebata, T; Kodera, Y

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 86 ( 1 ) page: 43 - 51   2024.2

     More details

  40. A multi-institutional prospective study to compare postoperative quality of life of patients who undergo proximal or total gastrectomy for early gastric cancer (CCOG1602).

    Kanda, M; Mochizuki, Y; Tanaka, C; Ito, S; Watanabe, T; Sueoka, S; Ishiyama, A; Yamada, T; Oshima, T; Hattori, M; Koike, S; Ishigure, K; Teramoto, H; Murotani, K; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 42 ( 3_SUPPL ) page: 296 - 296   2024.1

  41. Proposal of the second cutoff of serum carcinoembryonic antigen levels to stratify patients into low, intermediate, and high risks at recurrences after curative resection of gastric cancer

    Sato, B; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Nakanishi, K; Shimizu, D; Tanaka, C; Fujiwara, M; Murotani, K; Kodera, Y

    DIGESTIVE SURGERY   Vol. 40 ( 6 ) page: 187 - 195   2023.12

     More details

  42. Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients Open Access

    Shinozuka, T; Kanda, M; Sato, Y; Shimizu, D; Tanaka, C; Umeda, S; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

    CANCER MEDICINE   Vol. 12 ( 24 ) page: 22185 - 22195   2023.12

     More details

  43. Risk Stratification by Tissue<i> GAD1</i> Expression Level in Curatively Resected Esophageal Squamous Cell Carcinoma Open Access

    Kishida, T; Kanda, M; Sato, Y; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    CANCER GENOMICS & PROTEOMICS   Vol. 20 ( 6 ) page: 617 - 625   2023.11

     More details

  44. Predictive impacts of peritoneal washing cytology for surgical resection-intended pancreatic cancer cases: Establishment of planned staging laparoscopy criteria

    Tanaka, N; Takami, H; Hayashi, M; Inokawa, Y; Kurimoto, K; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   Vol. 30 ( 11 ) page: 1273 - 1281   2023.11

     More details

  45. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA &gt; 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer Open Access

    Nakanishi, K; Tanaka, C; Kanda, M; Miyata, K; Furukawa, K; Maeda, O; Shimizu, D; Sugita, S; Kakushima, N; Furune, S; Kawashima, H; Ando, Y; Ebata, T; Kodera, Y

    CANCERS   Vol. 15 ( 21 )   2023.11

     More details

  46. Modified Albumin-Bilirubin Grade optimized for risk stratification of patients with stage II-III gastric cancer

    Shoka, M; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Shimizu, D; Tanaka, C; Fujiwara, M; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 53 ( 10 ) page: 1149 - 1159   2023.10

     More details

  47. Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers Open Access

    Shinozuka, T; Kanda, M; Shimizu, D; Umeda, S; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    SCIENTIFIC REPORTS   Vol. 13 ( 1 ) page: 15540   2023.9

  48. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy

    Obata, Y; Kanda, M; Shimizu, D; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    SURGERY TODAY   Vol. 53 ( 8 ) page: 964 - 972   2023.8

     More details

  49. High Preoperative Platelet to Lymphocyte Ratio is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment

    Sasahara, M; Kanda, M; Shimizu, D; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Fujiwara, M; Nakayama, G; Kodera, Y

    DIGESTIVE SURGERY   Vol. 40 ( 1-2 ) page: 48 - 57   2023.7

     More details

  50. High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients

    Otsu, T; Hayashi, M; Takami, H; Inokawa, Y; Tanaka, N; Kurimoto, K; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANTICANCER RESEARCH   Vol. 43 ( 7 ) page: 3173 - 3181   2023.7

     More details

  51. OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus Open Access

    Shimizu, D; Kanda, M; Kishida, T; Nakamura, S; Sasahara, M; Ueda, S; Sato, Y; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Motoyama, S; Kodera, Y

    CANCER GENOMICS & PROTEOMICS   Vol. 20 ( 4 ) page: 343 - 353   2023.7

     More details

  52. Significance of the comprehensive geriatric assessment in the administration of chemotherapy to older adults with cancer: Recommendations by the Japanese Geriatric Oncology Guideline Committee Open Access

    Ninomiya, K; Inoue, D; Sugimoto, K; Tanaka, C; Murofushi, K; Okuyama, T; Watanuki, S; Imamura, CK; Sakai, D; Sakurai, N; Watanabe, K; Tamura, K; Saeki, T; Ishiguro, H

    JOURNAL OF GERIATRIC ONCOLOGY   Vol. 14 ( 5 ) page: 101485   2023.6

  53. Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection Open Access

    Hayashi, M; Kobayashi, D; Takami, H; Inokawa, Y; Tanaka, N; Kurimoto, K; Nakanishi, K; Umeda, S; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL   Vol. 75 ( 5 ) page: 1330 - 1339   2023.5

  54. Risk score for predicting death from other causes after curative gastrectomy for gastric cancer Open Access

    Ito, Y; Miwa, T; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    GASTRIC CANCER   Vol. 26 ( 2 ) page: 317 - 323   2023.3

     More details

  55. Proposal of a coagulation score to predict postoperative survival of patients undergoing neoadjuvant therapy followed by subtotal esophagectomy for squamous cell carcinoma of the esophagus.

    Sugiyama, F; Shimizu, D; Kanda, M; Tanaka, C; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 41   page: 448 - 448   2023.2

     More details

  56. Perioperative changes in geriatric functions of elderly patients undergoing surgical resection for gastric cancer.

    Tanaka, C; Kanda, M; Nakanishi, K; Umeda, S; Shimizu, D; Inokawa, Y; Takami, H; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y; Hattori, N

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 41   page: 811 - 811   2023.2

     More details

  57. Preoperative neutrophil-to-platelet ratio as a potential prognostic factor for gastric cancer with positive peritoneal lavage cytology in the absence of other non-curative factors: a multi-institutional dataset analysis

    Nonogaki, A; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 53 ( 2 ) page: 198 - 206   2023.2

     More details

  58. Preoperative indocyanine green fluorescence injection to accurately determine a proximal margin during robotic distal gastrectomy

    Nakanishi, K; Tanaka, C; Kanda, M; Shimizu, D; Furukawa, K; Fujiwara, M; Kawashima, H; Kodera, Y

    ASIAN JOURNAL OF ENDOSCOPIC SURGERY   Vol. 16 ( 1 ) page: 152 - 156   2023.1

     More details

  59. ASO Visual Abstract: Gamma-Aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer

    Sawaki, K; Kanda, M; Baba, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 30 ( 1 ) page: 639 - 640   2023.1

     More details

  60. Controlling Nutritional Status Score Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma: Optimal Timing of Evaluation of Patients Undergoing Neoadjuvant Treatment

    Nonogaki, I; Kanda, M; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Koike, M; Nakayama, G; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 47 ( 1 ) page: 217 - 226   2023.1

     More details

  61. Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer

    Sawaki, K; Kanda, M; Baba, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 30 ( 1 ) page: 628 - 636   2023.1

     More details

  62. A Multicenter Randomized Phase II Trial Investigating the Effect of Polyglycolic Acid Sheet on the Prevention of Pancreatic Fistula After Gastrectomy with Prophylactic Lymph Node Dissection Open Access

    Shimizu, D; Tanaka, C; Kanda, M; Nakanishi, K; Ito, S; Kuwatsuka, Y; Ando, M; Murotani, K; Fujiwara, M; Kodera, Y

    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY   Vol. 16   page: 169 - 172   2023

     More details

  63. Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

    Yamanaka, M; Hayashi, M; Sonohara, F; Yamada, S; Tanaka, H; Sakai, A; Mii, S; Kobayashi, D; Kurimoto, K; Tanaka, N; Inokawa, Y; Takami, H; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 29 ( 11 ) page: 7180 - 7189   2022.10

     More details

  64. ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

    Yamanaka, M; Hayashi, M; Sonohara, F; Yamada, S; Tanaka, H; Sakai, A; Mii, S; Kobayashi, D; Kurimoto, K; Tanaka, N; Inokawa, Y; Takami, H; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 29 ( 11 ) page: 7192 - 7193   2022.10

     More details

  65. Transcriptomic profiling on localized gastric cancer identified <i>CPLX1</i> as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy Open Access

    Tanaka, H; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Kodera, Y

    JOURNAL OF GASTROENTEROLOGY   Vol. 57 ( 9 ) page: 640 - 653   2022.9

     More details

  66. ASO Visual Abstract: Prognostic Value of a Modified Albumin-Bilirubin Grade Designed for Patients with Esophageal Squamous Cell Carcinoma after Radical Resection Open Access

    Shinozuka, T; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Koike, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 29 ( 8 ) page: 4899 - 4899   2022.8

     More details

  67. Prognostic Value of a Modified Albumin-Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection

    Shinozuka, T; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Koike, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 29 ( 8 ) page: 4889 - 4896   2022.8

     More details

  68. Comparison Between FOLFIRINOX and nal-IRI/FL as Second-line Treatment After Gemcitabine Plus Nab-paclitaxel for Pancreatic Cancer br

    Otsu, T; Inokawa, Y; Takami, H; Hayashi, M; Kurimoto, K; Tanaka, N; Tanaka, H; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Kodera, Y

    ANTICANCER RESEARCH   Vol. 42 ( 8 ) page: 3889 - 3894   2022.8

     More details

  69. E-PASS scoring system serves as a predictor of short- and long-term outcomes in gastric cancer surgery

    Nakanishi, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Kobayashi, D; Shimizu, D; Tanaka, C; Fujiwara, M; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 52 ( 6 ) page: 914 - 922   2022.6

     More details

  70. Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer Open Access

    Sakata, K; Kanda, M; Shimizu, D; Nakamura, S; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    INTERNATIONAL JOURNAL OF ONCOLOGY   Vol. 60 ( 6 )   2022.6

     More details

  71. Direct Observation of Retinal Microvessels in Cancer Patients After Systemic Administration of Bevacizumab and Oxaliplatin.

    Mitsuma A, Ito Y, Shimokata T, Tanaka C, Uehara K, Nakayama G, Terasaki H, Ando Y

    Cancer diagnosis & prognosis   Vol. 2 ( 3 ) page: 330 - 335   2022.5

     More details

    Language:English  

    DOI: 10.21873/cdp.10113

    PubMed

  72. Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells Open Access

    Umeda, S; Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Kodera, Y

    GASTRIC CANCER   Vol. 25 ( 3 ) page: 558 - 572   2022.5

     More details

  73. Prognostic impact of a microscopic positive margin in patients undergoing gastrectomy for gastric cancer: a propensity score-matched analysis of a multi-institutional dataset

    Nakanishi, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Shimizu, D; Tanaka, C; Fujiwara, M; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 52 ( 4 ) page: 559 - 566   2022.4

     More details

  74. Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline Open Access

    Iwama, S; Kobayashi, T; Yasuda, Y; Okuji, T; Ito, M; Ando, M; Zhou, X; Yamagami, A; Onoue, T; Kawaguchi, Y; Miyata, T; Sugiyama, M; Takagi, H; Hagiwara, D; Suga, H; Banno, R; Hase, T; Morise, M; Wakahara, K; Yokota, K; Kato, M; Nishio, N; Tanaka, C; Miyata, K; Ogura, A; Ito, T; Sawada, T; Shimokata, T; Niimi, K; Ohka, F; Ishigami, M; Gotoh, M; Hashimoto, N; Saito, R; Kiyoi, H; Kajiyama, H; Ando, Y; Hibi, H; Sone, M; Akiyama, M; Kodera, Y; Arima, H

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM   Vol. 107 ( 4 ) page: E1620 - E1630   2022.3

     More details

  75. Drain Amylase Concentrations at 3 h After Gastrectomy Enhance Early Prediction of Postoperative Peripancreatic Inflammatory Fluid Collection

    Nakanishi, K; Kanda, M; Tanaka, C; Takeda, S; Tanaka, K; Shimizu, D; Inokawa, Y; Hattori, N; Hayashi, M; Nakayama, G; Fujiwara, M; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 46 ( 3 ) page: 648 - 655   2022.3

     More details

  76. Effects of creating a jejunal pouch on postoperative quality of life after total gastrectomy: A cross-sectional study Open Access

    Tsuji, T; Isobe, T; Seto, Y; Tanaka, C; Kojima, K; Motoori, M; Ikeda, M; Nitta, T; Oshio, A; Nakada, K

    ANNALS OF GASTROENTEROLOGICAL SURGERY   Vol. 6 ( 1 ) page: 63 - 74   2022.1

     More details

  77. Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy Open Access

    Sunagawa, Y; Hayashi, M; Yamada, S; Tanabe, H; Kurimoto, K; Tanaka, N; Sonohara, F; Inokawa, Y; Takami, H; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    CLINICAL EPIGENETICS   Vol. 13 ( 1 ) page: 172   2021.12

  78. Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial Open Access

    Kanda, M; Shimizu, D; Miyata, K; Maeda, O; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Ando, M; Kuwatsuka, Y; Murotani, K; Nakayama, G; Koike, M; Ando, Y; Ebata, T; Kodera, Y

    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS   Vol. 24   page: 100853   2021.12

  79. Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells

    Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Umeda, S; Miwa, T; Tanaka, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Iguchi, Y; Katsuno, M; Kodera, Y

    ONCOGENE   Vol. 40 ( 36 ) page: 5495 - 5504   2021.9

     More details

  80. Surgical outcomes in gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2019. Open Access

    Marubashi S, Takahashi A, Kakeji Y, Hasegawa H, Ueno H, Eguchi S, Endo I, Goi T, Saiura A, Sasaki A, Takiguchi S, Takeuchi H, Tanaka C, Hashimoto M, Hiki N, Horiguchi A, Masaki T, Yoshida K, Gotoh M, Konno H, Yamamoto H, Miyata H, Seto Y, Kitagawa Y, National Clinical Database.

    Annals of gastroenterological surgery   Vol. 5 ( 5 ) page: 639 - 658   2021.9

     More details

  81. Efficacy of Splenectomy for Proximal Gastric Cancer with Greater Curvature Invasion or Type 4 Tumor: a Propensity Score Analysis of a Multi-Institutional Dataset

    Ito, S; Kanda, M; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 45 ( 9 ) page: 2840 - 2848   2021.9

     More details

  82. A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes

    Yamanaka, M; Hayashi, M; Yamada, S; Sonohara, F; Takami, H; Inokawa, Y; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 41 ( 8 ) page: 3933 - 3940   2021.8

     More details

  83. Accurate Prediction of Prognosis After Radical Resection of Gastric Cancer by the Modified Systemic Inflammation Score; a Multicenter Dataset Analysis Open Access

    Inagaki, K; Kanda, M; Nakanishi, K; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 45 ( 8 ) page: 2513 - 2520   2021.8

     More details

  84. G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer Open Access

    Tanaka, H; Kanda, M; Miwa, T; Umeda, S; Sawaki, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

    BRITISH JOURNAL OF CANCER   Vol. 125 ( 2 ) page: 220 - 228   2021.7

     More details

  85. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences

    Hayashi, M; Yamada, S; Tanabe, H; Takami, H; Inokawa, Y; Sonohara, F; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL   Vol. 73 ( 6 ) page: 996 - 1003   2021.7

     More details

  86. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma Open Access

    Nakagawa, N; Sonohara, F; Tanaka, K; Sunagawa, Y; Inokawa, Y; Takami, H; Hayashi, M; Yamada, S; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    ONCOLOGY LETTERS   Vol. 22 ( 1 ) page: 538   2021.7

     More details

  87. <i>miR</i>-<i>23b</i>-<i>3p</i> Plays an Oncogenic Role in Hepatocellular Carcinoma

    Hayashi, M; Yamada, S; Kurimoto, K; Tanabe, H; Hirabayashi, S; Sonohara, F; Inokawa, Y; Takami, H; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 28 ( 6 ) page: 3416 - 3426   2021.6

     More details

  88. Short-term outcomes of gastrectomy after neoadjuvant chemotherapy for clinical stage III gastric cancer: propensity score-matched analysis of a multi-institutional database

    Umeda, S; Kanda, M; Nakanishi, K; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Shimizu, D; Kobayashi, D; Tanaka, C; Fujiwara, M; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 51 ( 5 ) page: 821 - 828   2021.5

     More details

  89. Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma Open Access

    Hayashi, M; Yamada, S; Takano, N; Okamura, Y; Takami, H; Inokawa, Y; Sonohara, F; Tanaka, N; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    IN VIVO   Vol. 35 ( 3 ) page: 1749 - 1760   2021.5

     More details

  90. Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway Open Access

    Miwa, T; Kanda, M; Shimizu, D; Umeda, S; Sawaki, K; Tanaka, H; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

    BRITISH JOURNAL OF CANCER   Vol. 124 ( 8 ) page: 1449 - 1460   2021.4

  91. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma Reviewed

    Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 28 ( 4 ) page: 2277 - 2286   2021.4

     More details

  92. Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue Reviewed Open Access

    Sunagawa, Y; Yamada, S; Sonohara, F; Kurimoto, K; Tanaka, N; Suzuki, Y; Inokawa, Y; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    SCIENTIFIC REPORTS   Vol. 11 ( 1 ) page: 6016   2021.3

  93. Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody

    Hasegawa, H; Sugiyama, D; Kanda, M; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Koike, M; Nomoto, S; Fujiwara, M; Kodera, Y; Nishikawa, H

    CANCER SCIENCE   Vol. 112   page: 741 - 741   2021.2

     More details

    Language:Japanese  

    Web of Science

  94. Function and prognostic value of melanoma-associated antigen-D4 protein in esophageal squamous cell carcinoma

    Sawaki, K; Kanda, M; Sato, Y; Shimizu, D; Uno, Y; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Fujiwara, M; Kodera, Y

    CANCER SCIENCE   Vol. 112   page: 531 - 531   2021.2

     More details

    Language:Japanese  

    Web of Science

  95. STRA6 expression serves as a prognostic biomarker of gastric cancer Open Access

    Nakamura, S; Kanda, M; Shimizu, D; Sawaki, K; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Koike, M; Kodera, Y

    CANCER SCIENCE   Vol. 112   page: 780 - 780   2021.2

     More details

  96. Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)

    Nakayama, G; Takano, N; Taniguchi, H; Ishigure, K; Yokoyama, H; Teramoto, H; Hashimoto, R; Sakai, M; Ishiyama, A; Kinoshita, T; Hayashi, N; Nakamura, M; Hattori, N; Sato, Y; Umeda, S; Uehara, K; Aiba, T; Sonohara, F; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Murotani, K; Ando, M; Ando, Y; Muro, K; Kodera, Y

    EUROPEAN JOURNAL OF CANCER   Vol. 144   page: 61 - 71   2021.2

     More details

  97. Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer Open Access

    Sasahara Masahiro, Kanda Mitsuro, Shimizu Dai, Tanaka Chie, Inokawa Yoshikuni, Hattori Norifumi, Hayashi Masamichi, Nakayama Goro, Kodera Yasuhiro

    ANTICANCER RESEARCH   Vol. 41 ( 2 ) page: 609 - 617   2021.2

  98. Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer Open Access

    Sasahara Masahiro, Kanda Mitsuro, Shimizu Dai, Tanaka Chie, Inokawa Yoshikuni, Hattori Norifumi, Hayashi Masamichi, Nakayama Goro, Kodera Yasuhiro

    ANTICANCER RESEARCH   Vol. 41 ( 2 ) page: 609 - 617   2021.2

  99. Tissue <i>RNFT2</i> Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer. Open Access

    Sasahara M, Kanda M, Shimizu D, Tanaka C, Inokawa Y, Hattori N, Hayashi M, Nakayama G, Kodera Y

    Anticancer research   Vol. 41 ( 2 ) page: 609 - 617   2021.2

  100. Age-Related Differences in the Prognosis of Pancreatic Cancer According to Perioperative Systemic Therapy

    Sonohara, F; Yamada, S; Kurimoto, K; Inokawa, Y; Takami, H; Hayashi, M; Shimizu, D; Hattori, N; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Fujii, T; Kodera, Y

    PANCREAS   Vol. 50 ( 1 ) page: 37 - 46   2021.1

     More details

  101. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus

    Shimizu, D; Koike, M; Kanda, M; Sonohara, F; Hattori, N; Hayashi, M; Tanaka, C; Yamada, S; Kodera, Y

    SURGERY TODAY   Vol. 51 ( 1 ) page: 153 - 158   2021.1

     More details

  102. Pancreatic Fat and Body Composition Measurements by Computed Tomography are Associated with Pancreatic Fistula After Pancreatectomy

    Tanaka, K; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 28 ( 1 ) page: 530 - 538   2021.1

     More details

  103. AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer Open Access

    Nakamura, S; Kanda, M; Shimizu, D; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 40 ( 12 ) page: 6713 - 6721   2020.12

     More details

  104. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue Open Access

    Nakagawa, N; Tanaka, K; Sonohara, F; Kandimalla, R; Sunagawa, Y; Inokawa, Y; Takami, H; Hayashi, M; Yamada, S; Kanda, M; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 40 ( 12 ) page: 6665 - 6676   2020.12

     More details

  105. Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio

    Nakamura, S; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 44 ( 12 ) page: 4184 - 4192   2020.12

     More details

  106. AnOpen-Label Single-ArmPhaseIIStudy of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical StageIIISquamous Cell Carcinoma of the Esophagus Open Access

    Kanda, M; Koike, M; Iwata, N; Shimizu, D; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Omae, K; Nakayama, G; Kodera, Y

    ONCOLOGIST   Vol. 25 ( 11 ) page: E1650 - E1654   2020.11

     More details

  107. D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset

    Shinozuka, T; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    SURGERY TODAY   Vol. 50 ( 11 ) page: 1434 - 1442   2020.11

     More details

  108. Characteristics Associated with Nodal and Distant Recurrence after Curative Resection of Squamous Cell Carcinoma of the Thoracic Esophagus

    Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Hayashi, M; Hattori, N; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS   Vol. 231 ( 4 ) page: E121 - E121   2020.10

     More details

    Language:Japanese  

    Web of Science

  109. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus

    Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Omae, K; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 9 ) page: 3195 - 3205   2020.9

     More details

  110. STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer Open Access

    Nakamura, S; Kanda, M; Shimizu, D; Sawaki, K; Tanaka, C; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

    CANCER GENOMICS & PROTEOMICS   Vol. 17 ( 5 ) page: 509 - 516   2020.9

     More details

  111. Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional Dataset

    Shoka, M; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    DIGESTIVE SURGERY   Vol. 37 ( 5 ) page: 401 - 410   2020.9

     More details

  112. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer Open Access

    Kanda, M; Shimizu, D; Sawaki, K; Nakamura, S; Umeda, S; Miwa, T; Tanaka, H; Tanaka, C; Hayashi, M; Iguchi, Y; Yamada, S; Katsuno, M; Kodera, Y

    MOLECULAR CANCER   Vol. 19 ( 1 ) page: 131   2020.8

  113. The impact of cancer stem cell markers in the tissues of pancreatic ductal adenocarcinoma for prognosis after surgical resections

    Inokawa, Y; Yamada, S; Hayashi, M; Sunagawa, Y; Sonohara, F; Takami, H; Hattori, N; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Kodera, Y

    CANCER RESEARCH   Vol. 80 ( 16 )   2020.8

     More details

  114. Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer Open Access

    Sawaki, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    CANCER MEDICINE   Vol. 9 ( 15 ) page: 5392 - 5399   2020.8

     More details

  115. <i>KCNJ15</i> Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma

    Nakamura, S; Kanda, M; Koike, M; Shimizu, D; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Omae, K; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 7 ) page: 2559 - 2568   2020.7

     More details

  116. Propensity-score-matched analysis of a multi-institutional dataset to compare postoperative complications between Billroth I and Roux-en-Y reconstructions after distal gastrectomy Open Access

    Nakanishi, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Shimizu, D; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    GASTRIC CANCER   Vol. 23 ( 4 ) page: 734 - 745   2020.7

     More details

  117. Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer

    Sunagawa, Y; Yamada, S; Sato, Y; Morimoto, D; Sonohara, F; Takami, H; Inokawa, Y; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 6 ) page: 2081 - 2089   2020.6

     More details

  118. <i>PRAME</i> as a Potential Biomarker for Liver Metastasis of Gastric Cancer

    Baba, H; Kanda, M; Sawaki, K; Umeda, S; Miwa, T; Shimizu, D; Tanaka, C; Kobayashi, D; Fujiwara, M; Kodera, Y; Fujii, T

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 6 ) page: 2071 - 2080   2020.6

     More details

  119. Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer Open Access

    Umeda, S; Kanda, M; Miwa, T; Tanaka, H; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

    INTERNATIONAL JOURNAL OF CANCER   Vol. 146 ( 10 ) page: 2865 - 2876   2020.5

     More details

  120. Characteristics of Lung Metastasis as an Initial Recurrence Pattern After Curative Resection of Pancreatic Cancer

    Morimoto, D; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

    PANCREAS   Vol. 49 ( 5 ) page: 699 - 705   2020.5

     More details

  121. Clinical impact of additional therapy for residual pancreatic cancer

    Yamada, S; Sonohara, F; Tashiro, M; Murotani, K; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujii, T; Kodera, Y

    SURGERY TODAY   Vol. 50 ( 5 ) page: 440 - 448   2020.5

     More details

  122. Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study.

    Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y

    Asian journal of endoscopic surgery   Vol. 13 ( 2 ) page: 160 - 167   2020.4

     More details

  123. Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Open Access

    Sonohara, F; Yamada, S; Takeda, S; Hayashi, M; Suenaga, M; Sunagawa, Y; Tashiro, M; Takami, H; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 40 ( 4 ) page: 1843 - 1853   2020.4

     More details

  124. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus

    Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Hattori, N; Hayashi, M; Omae, K; Yamada, S; Nakayama, G; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 4 ) page: 1233 - 1240   2020.4

     More details

  125. Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer Open Access

    Nakagawa, N; Yamada, S; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 3 ) page: 887 - 895   2020.3

  126. Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+or pT2-3N0 Gastric Cancer: a Multi-institutional Dataset Analysis Open Access

    Fujita, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    JOURNAL OF GASTRIC CANCER   Vol. 20 ( 1 ) page: 41 - 49   2020.3

     More details

  127. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study Open Access

    Kanda, M; Suh, YS; Park, DJ; Tanaka, C; Ahn, SN; Kong, SH; Lee, HJ; Kobayashi, D; Fujiwara, M; Shimada, H; Cho, B; Murotani, K; Kim, HH; Yang, HK; Kodera, Y

    GASTRIC CANCER   Vol. 23 ( 2 ) page: 203 - 211   2020.3

     More details

  128. Predictive value of the modified systemic inflammation score in patients undergoing curative resection of squamous cell carcinoma of the esophagus

    Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Sonohara, F; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 38 ( 4 )   2020.2

     More details

    Language:Japanese  

    Web of Science

  129. Propensity-score-matched analysis of a multi-institutional dataset to compare the postoperative complications after distal gastrectomy between Billroth I and Roux-en-Y

    Nakanishi, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Mmurai, T; Asada, T; Ishiyama, A; Matsushita, H; Shimizu, D; Tanaka, C; Kobayashi, D; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 38 ( 4 )   2020.2

     More details

    Language:Japanese  

    Web of Science

  130. A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage a the anastomotic site after esophagectomy Open Access

    Kanda, M; Koike, M; Fukaya, M; Miyata, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Murotani, K; Fujiwara, M; Nagino, M; Kodera, Y

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 82 ( 1 ) page: 33 - 37   2020.2

     More details

  131. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis

    Kobayashi, D; Ishigami, H; Kanda, M; Tanaka, C; Yamaguchi, H; Kitayama, J; Kodera, Y

    ONCOLOGY   Vol. 98 ( 1 ) page: 48 - 52   2020.1

     More details

  132. The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness Open Access

    Hirabayashi, S; Hayashi, M; Nakayama, G; Mii, S; Hattori, N; Tanabe, H; Kanda, M; Tanaka, C; Kobayashi, D; Yamada, S; Koike, M; Fujiwara, M; Takahashi, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 40 ( 1 ) page: 201 - 211   2020.1

     More details

  133. Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II) Open Access

    Hattori, N; Nakayama, G; Uehara, K; Aiba, T; Ishigure, K; Sakamoto, E; Tojima, Y; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Nagino, M; Kodera, Y

    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 25 ( 1 ) page: 118 - 125   2020.1

  134. Tumor size ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset

    Tsutsuyama, M; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 44 ( 1 ) page: 194 - 201   2020.1

     More details

  135. Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset

    Ito, Y; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 27 ( 1 ) page: 268 - 275   2020.1

     More details

  136. The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset

    Sasahara, M; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    DIGESTIVE SURGERY   Vol. 37 ( 2 ) page: 135 - 144   2020

     More details

  137. Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus

    Kanda, M; Koike, M; Tanaka, C; Kobayashi, D; Hattori, N; Hayashi, M; Yamada, S; Omae, K; Fujiwara, M; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 26 ( 13 ) page: 4773 - 4781   2019.12

     More details

  138. Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma

    Sonohara, F; Yamada, S; Tanaka, N; Tashiro, M; Sunagawa, Y; Morimoto, D; Tanaka, H; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    HEPATOLOGY RESEARCH   Vol. 49 ( 11 ) page: 1305 - 1315   2019.11

     More details

  139. Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines Open Access

    Miwa, T; Kanda, M; Umeda, S; Tanaka, H; Shimizu, D; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

    IN VIVO   Vol. 33 ( 6 ) page: 1785 - 1792   2019.11

     More details

  140. Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma Open Access

    Uno, Y; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 39 ( 11 ) page: 6015 - 6023   2019.11

     More details

  141. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer Open Access

    Endo, M; Kanda, M; Sawaki, K; Shimizu, D; Tanaka, C; Kobayashi, D; Hattori, N; Hayashi, M; Yamada, S; Koike, M; Omae, K; Kodera, Y

    ANTICANCER RESEARCH   Vol. 39 ( 11 ) page: 5903 - 5910   2019.11

     More details

  142. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer Open Access

    Nakanishi, K; Kanda, M; Umeda, S; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Kodera, Y

    GASTRIC CANCER   Vol. 22 ( 6 ) page: 1143 - 1152   2019.11

     More details

  143. Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer Open Access

    Sawaki, K; Kanda, M; Umeda, S; Miwa, T; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

    ANTICANCER RESEARCH   Vol. 39 ( 11 ) page: 6125 - 6133   2019.11

     More details

  144. Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset Open Access

    Nakanishi, K; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    GASTRIC CANCER   Vol. 22 ( 6 ) page: 1215 - 1225   2019.11

     More details

  145. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma

    Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

    PANCREAS   Vol. 48 ( 10 ) page: 1528 - 1528   2019.11

     More details

    Language:Japanese  

    Web of Science

  146. Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis Open Access

    Kanda, M; Koike, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Kodera, Y

    BMC SURGERY   Vol. 19 ( 1 ) page: 143   2019.10

  147. Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens

    Sonohara, F; Yamada, S; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

    EJSO   Vol. 45 ( 10 ) page: 1895 - 1900   2019.10

     More details

  148. Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations

    Kanda, M; Koike, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Omae, K; Kodera, Y

    ANNALS OF SURGICAL ONCOLOGY   Vol. 26 ( 11 ) page: 3718 - 3726   2019.10

     More details

  149. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer Open Access

    Kato, Y; Yamada, S; Tashiro, M; Sonohara, F; Takami, H; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    HPB   Vol. 21 ( 9 ) page: 1211 - 1218   2019.9

     More details

  150. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer Open Access

    Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    CANCER MEDICINE   Vol. 8 ( 11 ) page: 5194 - 5201   2019.9

     More details

  151. Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis

    Iizuka, A; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    WORLD JOURNAL OF SURGERY   Vol. 43 ( 8 ) page: 2016 - 2024   2019.8

     More details

  152. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Open Access

    Hayashi S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association   Vol. 22 ( 4 ) page: 853 - 863   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10120-018-0902-2

    Web of Science

    PubMed

  153. Functions of FRAS1 as a driver gene of liver metastasis from gastric cancer analyzed by the genome editing technology

    Umeda, S; Kanda, M; Tanaka, H; Sonohara, F; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    CANCER RESEARCH   Vol. 79 ( 13 )   2019.7

     More details

  154. Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy Open Access

    Miwa, T; Kanda, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

    JOURNAL OF GASTRIC CANCER   Vol. 19 ( 2 ) page: 183 - 192   2019.6

     More details

  155. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.

    Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y

    Annals of surgical oncology   Vol. 26 ( 5 ) page: 1535 - 1543   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-019-07166-5

    Web of Science

    PubMed

  156. Long-term quality of life and nutrition status of the aboral pouch reconstruction after total gastrectomy for gastric cancer: a prospective multicenter observational study (CCOG1505). Open Access

    Tanaka C, Kanda M, Murotani K, Yoshikawa T, Cho H, Ito Y, Matsui T, Nakayama H, Yamada T, Kobayashi D, Fujiwara M, Kodera Y

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association   Vol. 22 ( 3 ) page: 607 - 616   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10120-018-0893-z

    Web of Science

    PubMed

  157. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.

    Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y

    Annals of surgical oncology   Vol. 26 ( 3 ) page: 836 - 844   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-018-07149-y

    Web of Science

    PubMed

  158. Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset.

    Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y

    World journal of surgery   Vol. 43 ( 3 ) page: 870 - 877   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00268-018-4834-0

    Web of Science

    PubMed

  159. Prediction of peritoneal recurrences of gastric cancer by qPCR analysis of peritoneal lavage fluids.

    Nakanishi, K; Kanda, M; Umeda, S; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 37 ( 4 )   2019.2

  160. The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set.

    Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y

    Annals of surgical oncology   Vol. 26 ( 2 ) page: 456 - 464   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-018-07121-w

    Web of Science

    PubMed

  161. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer Open Access

    Suenaga, Y; Kanda, M; Ito, S; Mochizuki, Y; Teramoto, H; Ishigure, K; Murai, T; Asada, T; Ishiyama, A; Matsushita, H; Tanaka, C; Kobayashi, D; Fujiwara, M; Murotani, K; Kodera, Y

    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY   Vol. 11 ( 1 ) page: 17 - 27   2019.1

     More details

  162. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy Open Access

    Niwa Yukiko, Yamada Suguru, Sonohara Fuminori, Kurimoto Keisuke, Hayashi Masamichi, Tashiro Mitsuru, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    JOURNAL OF TRANSLATIONAL MEDICINE   Vol. 17 ( 1 ) page: 1   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12967-018-1762-6

    Open Access

    Web of Science

    PubMed

  163. Optical trocar access for initial trocar placement in laparoscopic gastrointestinal surgery: A propensity score-matching analysis.

    Tanaka C, Fujiwara M, Kanda M, Murotani K, Iwata N, Hayashi M, Kobayashi D, Yamada S, Kodera Y

    Asian journal of endoscopic surgery   Vol. 12 ( 1 ) page: 37 - 42   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/ases.12484

    Web of Science

    PubMed

  164. Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma Open Access

    Sonohara, F; Yamada, S; Tanaka, N; Suenaga, M; Takami, H; Hayashi, M; Niwa, Y; Sugimoto, H; Hattori, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

    ANNALS OF GASTROENTEROLOGICAL SURGERY   Vol. 3 ( 1 ) page: 65 - 74   2019.1

     More details

  165. Homeobox C10 correlates with the malignant phenotype of gastric cancer and its recurrence and poor survival

    Miwa Takashi, Kanda Mitsuro, Tanaka Chie, Yamada Suguru, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 1127 - 1127   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  166. FRAS1 expression reflects the malignancy potential of gastric cancer

    Umeda Shinichi, Kanda Mitsuro, Tanaka Chie, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 1128 - 1128   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  167. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma Open Access

    Umeda Shinichi, Kanda Mitsuro, Koike Masahiko, Tanaka Haruyoshi, Miwa Takashi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Kodera Yasuhiro

    ONCOLOGY REPORTS   Vol. 40 ( 6 ) page: 3772 - 3780   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/or.2018.6742

    Web of Science

    PubMed

  168. A New Biomarker for Peritoneal Lavage Using Digital PCR in Patients with Pancreatic Ductal Adenocarcinoma

    Suenaga Masaya, Yamada Suguru, Hayashi Masamichi, Kanda Mitsuro, Tanaka Chie, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 650 - 650   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  169. Integrated multigene expression panel to prognosticate patients with gastric cancer

    Kanda Mitsuro, Miwa Takashi, Umeda Shinichi, Tanaka Chie, Hayashi Masamichi, Suenaga Masaya, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 769 - 769   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  170. Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer

    Sawaki Koichi, Kanda Mitsuro, Suenaga Masaya, Hayashi Masamichi, Tanaka Chie, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 765 - 765   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  171. Pattern-specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer Open Access

    Tanaka Haruyoshi, Kanda Mitsuro, Suenaga Masaya, Hayashi Masamichi, Tanaka Chie, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 1128 - 1128   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1158/1541-7786.MCR-17-0467

    Web of Science

  172. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset Open Access

    Nakagawa Nobuhiko, Kanda Mitsuro, Ito Seiji, Mochizuki Yoshinari, Teramoto Hitoshi, Ishigure Kiyoshi, Murai Toshifumi, Asada Takahiro, Ishiyama Akiharu, Matsushita Hidenobu, Tanaka Chie, Kobayashi Daisuke, Fujiwara Michitaka, Murotani Kenta, Kodera Yasuhiro

    CANCER MEDICINE   Vol. 7 ( 12 ) page: 6020 - 6029   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/cam4.1868

    Open Access

    Web of Science

    PubMed

  173. Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification

    Morimoto Daishi, Yamada Suguru, Murotani Kenta, Sonohara Fuminori, Takami Hideki, Suenaga Masaya, Hayashi Masamichi, Niwa Yukiko, Tashiro Mitsuru, Hattori Norifumi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

    PANCREAS   Vol. 47 ( 10 ) page: 1350 - 1356   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MPA.0000000000001186

    Web of Science

    PubMed

  174. Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis

    Kobayashi Daisuke, Kanda Mitsuro, Tanaka Chie, Sonohara Fuminori, Suenaga Masaya, Takami Hideki, Hattori Norifumi, Niwa Yukiko, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 33   page: 98 - 98   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  175. Expression of sushi domain containing two reflects the malignant potential of gastric cancer Open Access

    Umeda Shinichi, Kanda Mitsuro, Miwa Takashi, Tanaka Haruyoshi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER MEDICINE   Vol. 7 ( 10 ) page: 5194 - 5204   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/cam4.1793

    Open Access

    Web of Science

    PubMed

  176. Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer

    Tashiro Mitsuru, Yamada Suguru, Sonohara Fuminori, Takami Hideki, Suenaga Masaya, Hayashi Masamichi, Niwa Yukiko, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

    ANNALS OF SURGICAL ONCOLOGY   Vol. 25 ( 11 ) page: 3365 - 3371   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-018-6699-8

    Web of Science

    PubMed

  177. Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2-4 Gastric Cancer After Radical Gastrectomy

    Sato Bin, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Iwata Naoki, Hattori Norifumi, Suenaga Masaya, Hayashi Masamichi, Yamada Suguru, Murotani Kenta, Fujiwara Michitaka, Kodera Yasuhiro

    WORLD JOURNAL OF SURGERY   Vol. 42 ( 10 ) page: 3277 - 3285   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00268-018-4597-7

    Web of Science

    PubMed

  178. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells

    Kanda Mitsuro, Tanaka Haruyoshi, Shimizu Dai, Miwa Takashi, Umeda Shinichi, Tanaka Chie, Kobayashi Daisuke, Hattori Norifumi, Suenaga Masaya, Hayashi Masamichi, Iwata Naoki, Yamada Suguru, Fujiwara Michitaka, Kodera Yasuhiro

    ONCOGENE   Vol. 37 ( 39 ) page: 5355 - 5366   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41388-018-0335-8

    Web of Science

    PubMed

  179. Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms.

    Yamada S, Fujii T, Hirakawa A, Takami H, Suenaga M, Hayashi M, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y

    Pancreas   Vol. 47 ( 8 ) page: 974 - 979   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MPA.0000000000001110

    Web of Science

    PubMed

  180. Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer Open Access

    Tanaka Haruyoshi, Kanda Mitsuro, Miwa Takashi, Tanaka Chie, Kobayashi Daisuke, Umeda Shinichi, Shibata Masahiro, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Iwata Naoki, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

    MOLECULAR CANCER RESEARCH   Vol. 16 ( 9 ) page: 1420 - 1429   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1158/1541-7786.MCR-17-0467

    Web of Science

    PubMed

  181. Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer

    Kanda M., Shimizu D., Tanaka H., Tanaka C., Kobayashi D., Hayashi M., Takami H., Niwa Y., Yamada S., Fujii T., Sugimoto H., Kodera Y.

    BRITISH JOURNAL OF SURGERY   Vol. 105 ( 10 ) page: 1349 - 1358   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/bjs.10876

    Web of Science

    PubMed

  182. Efficacy of enteral nutrients containing beta-hydroxy-beta-methylbutyrate, glutamine, and arginine for the patients with anastomotic leakage after gastrectomy: study protocol of a multicenter phase II clinical trial Open Access

    Kanda Mitsuro, Tanaka Chie, Murotani Kenta, Kobayashi Daisuke, Ito Seiji, Mochizuki Yoshinari, Ishigure Kiyoshi, Ishiyama Akiharu, Teramoto Hitoshi, Murai Toshifumi, Asada Takahiro, Matsushita Hidenobu, Fujiwara Michitaka, Kodera Yasuhiro

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 80 ( 3 ) page: 351 - 355   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.80.3.351

    Open Access

    Web of Science

    PubMed

  183. Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma

    Kato Yoshiyasu, Yamada Suguru, Suenaga Masaya, Takami Hideki, Niwa Yukiko, Hayashi Masamichi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    PANCREAS   Vol. 47 ( 7 ) page: 823 - 829   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MPA.0000000000001105

    Web of Science

    PubMed

  184. Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study) Open Access

    Nakayama Goro, Mitsuma Ayako, Sunagawa Yuki, Ishigure Kiyoshi, Yokoyama Hiroyuki, Matsui Takanori, Nakayama Hiroshi, Nakata Kazuhiko, Ishiyama Akiharu, Asada Takahiro, Umeda Shinichi, Ezaka Kazuhiro, Hattori Norifumi, Takami Hideki, Kobayashi Daisuke, Tanaka Chie, Kanda Mitsuro, Yamada Suguru, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Murotani Kenta, Ando Yuichi, Kodera Yasuhiro

    ONCOLOGIST   Vol. 23 ( 8 ) page: 919 - 927   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1634/theoncologist.2017-0640

    Web of Science

    PubMed

  185. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer

    Sawaki Koichi, Kanda Mitsuro, Miwa Takashi, Umeda Shinichi, Tanaka Haruyoshi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

    ANNALS OF SURGICAL ONCOLOGY   Vol. 25 ( 7 ) page: 2083 - 2090   2018.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-018-6480-z

    Web of Science

    PubMed

  186. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer Open Access

    Tanaka Nobutake, Yamada Suguru, Sonohara Fuminori, Suenaga Masaya, Hayashi Masamichi, Takami Hideki, Niwa Yukiko, Hattori Norifumi, Iwata Naoki, Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

    SCIENTIFIC REPORTS   Vol. 8 ( 1 ) page: 9846   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-018-28253-9

    Open Access

    Web of Science

    PubMed

  187. A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer Open Access

    Kanda Mitsuro, Murotani Kenta, Tanaka Haruyoshi, Miwa Takashi, Umeda Shinichi, Tanaka Chie, Kobayashi Daisuke, Hayashi Masamichi, Hattori Norifumi, Suenaga Masaya, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER MEDICINE   Vol. 7 ( 6 ) page: 2463 - 2471   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/cam4.1522

    Open Access

    Web of Science

    PubMed

  188. IDENTIFICATION OF MOLECULES DRIVING HEPATIC METASTASIS FORMATION OF GASTRIC CANCER CELLS Open Access

    Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Takami Hideki, Hattori Norifumi, Niwa Yukiko, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    GUT   Vol. 67   page: A5 - A5   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1136/gutjnl-2018-IDDFabstracts.12

    Web of Science

  189. Significance of Lysyl oxidase-like 2 gene expression on the epithelial-mesenchymal status of hepatocellular carcinoma Open Access

    Ninomiya Go, Yamada Suguru, Hayashi Masamichi, Takeda Shigeomi, Suenaga Masaya, Takami Hideki, Kanda Mitsuro, Iwata Naoki, Niwa Yukiko, Tanaka Chie, Kobayashi Daisuke, Fujii Tsutomu, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    ONCOLOGY REPORTS   Vol. 39 ( 6 ) page: 2664 - 2672   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/or.2018.6349

    Web of Science

    PubMed

  190. Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study)

    Asada Takahiro, Nakayama Goro, Tanaka Chie, Kobayashi Daisuke, Ezaka Kazuhiro, Hattori Norifumi, Kanda Mitsuro, Yamada Suguru, Koike Masahiko, Kodera Yasuhiro

    SURGERY TODAY   Vol. 48 ( 6 ) page: 609 - 617   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00595-018-1634-y

    Web of Science

    PubMed

  191. Integrated multigene expression panel to prognosticate patients with gastric cancer.

    Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y

    Oncotarget   Vol. 9 ( 27 ) page: 18775-18785   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18632/oncotarget.24661

    PubMed

  192. Preoperative Albumin-Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer. Reviewed

    Kanda M, Tanaka C, Kobayashi D, Uda H, Inaoka K, Tanaka Y, Hayashi M, Iwata N, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

    World journal of surgery   Vol. 42 ( 3 ) page: 773 - 781   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00268-017-4234-x

    Web of Science

    PubMed

  193. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Reviewed Open Access

    Kanda M, Shimizu D, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Iwata N, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

    Annals of surgery   Vol. 267 ( 3 ) page: 495 - 503   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/SLA.0000000000002096

    Open Access

    Web of Science

    PubMed

  194. Identification of a novel molecule target for the diagnosis, prediction, and treatment of hepatic metastasis of gastric cancer.

    Kanda Mitsuro, Tanaka Haruyoshi, Miwa Takashi, Kobayashi Daisuke, Tanaka Chie, Takami Hideki, Hayashi Masamichi, Iwata Naoki, Niwa Yukiko, Yamada Suguru, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 36 ( 4 ) page: .   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1200/JCO.2018.36.4_suppl.53

    Web of Science

  195. Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.

    Yamada Suguru, Fujii Tsutomu, Takano Nao, Takami Hideki, Suenaga Masaya, Niwa Yukiko, Hayashi Masamichi, Iwata Naoki, Kanda Mitsuro, Kobayashi Daisuke, Tanaka Chie, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 36 ( 4 ) page: .   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1200/JCO.2018.36.4_suppl.523

    Web of Science

  196. Clinical implication of nutrition for neoadjuvant therapy and impact of nutritional support in pancreatic cancer.

    Tashiro, M; Yamada, S; Fujii, T; Hattori, N; Takami, H; Suenaga, M; Niwa, Y; Hayashi, M; Iwata, N; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 36 ( 4 )   2018.2

  197. Oncogenic function of miR-23b-3p in hepatocellular carcinoma

    Masamichi Hayashi, Yamada Suguru, Kanda Mitsuro, Tanaka Chie, Fujiwara Michitaka, Kodera Yasuhiro

    CANCER SCIENCE   Vol. 109   page: 1123 - 1123   2018.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  198. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy. Reviewed Open Access

    Uda H, Kanda M, Tanaka C, Kobayashi D, Inaoka K, Tanaka Y, Hayashi M, Iwata N, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

    Digestive surgery   Vol. 35 ( 1 ) page: 55 - 63   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000471931

    Open Access

    Web of Science

    PubMed

  199. Nutritional Recovery after Open and Laparoscopic Distal Gastrectomy for Early Gastric Cancer: A Prospective Multicenter Comparative Trial (CCOG1204). Reviewed

    Matsushita H, Tanaka C, Murotani K, Misawa K, Ito S, Ito Y, Kanda M, Mochizuki Y, Ishigure K, Yaguchi T, Teramoto J, Nakayama H, Kawase Y, Fujiwara M, Kodera Y

    Digestive surgery   Vol. 35 ( 1 ) page: 11 - 18   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000458714

    Web of Science

    PubMed

  200. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells. Reviewed Open Access

    Miwa T, Kanda M, Tanaka H, Tanaka C, Kobayashi D, Umeda S, Iwata N, Hayashi M, Yamada S, Fujii T, Fujiwara M, Kodera Y

    Annals of surgical oncology   Vol. 24 ( 12 ) page: 3771 - 3779   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-017-5882-7

    Open Access

    Web of Science

    PubMed

  201. Identification of <i>NCCRP1</i> as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus. Reviewed Open Access

    Miwa T, Kanda M, Koike M, Iwata N, Tanaka H, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Fujii T, Fujiwara M, Kodera Y

    Oncology letters   Vol. 14 ( 4 ) page: 4822 - 4828   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ol.2017.6753

    Open Access

    Web of Science

    PubMed

  202. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer. Reviewed Open Access

    Tanaka H, Kanda M, Shimizu D, Tanaka C, Kobayashi D, Hayashi M, Iwata N, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Niwa Y, Kodera Y

    Annals of surgical oncology   Vol. 24 ( 11 ) page: 3438 - 3445   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-016-5636-y

    Open Access

    Web of Science

    PubMed

  203. Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society. Reviewed

    Yamada S, Fujii T, Takami H, Hayashi M, Iwata N, Kanda M, Tanaka C, Sugimoto H, Nakayama G, Koike M, Fujiwara M, Kodera Y

    Surgery   Vol. 162 ( 4 ) page: 784 - 791   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.surg.2017.04.023

    Web of Science

    PubMed

  204. An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma. Reviewed Open Access

    Kanda M, Murotani K, Sugimoto H, Miwa T, Umeda S, Suenaga M, Hayashi M, Hattori N, Tanaka C, Kobayashi D, Yamada S, Fujiwara M, Kodera Y

    Oncotarget   Vol. 8 ( 41 ) page: 71070 - 71079   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18632/oncotarget.20369

    Open Access

    Web of Science

    PubMed

  205. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma. Reviewed Open Access

    Umeda S, Kanda M, Sugimoto H, Tanaka H, Hayashi M, Yamada S, Fujii T, Takami H, Niwa Y, Iwata N, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y

    BMC cancer   Vol. 17 ( 1 ) page: 610   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12885-017-3629-2

    Open Access

    Web of Science

    PubMed

  206. Involvement of the immunoregulator MZB1 in progression of gastric cancer

    Tanaka Y., Kanda M., Tanaka C., Kobayashi D., Tanaka H., Takami H., Hayashi M., Iwata N., Niwa Y., Yamada S., Nakayama G., Sugimoto H., Koike M., Fujiwara M., Kodera Y.

    ANNALS OF ONCOLOGY   Vol. 28   page: .   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  207. Nutritional recovery after open and laparoscopic distal gastrectomy for early gastric cancer: A prospective multicenter comparative trial (CCOG1204)

    Tanaka, C; Kanda, M; Misawa, K; Ito, S; Ito, Y; Mochizuki, Y; Ishigure, K; Yaguchi, T; Teramoto, J; Nakayama, H; Kawase, Y; Fujiwara, M; Kodera, Y

    ANNALS OF ONCOLOGY   Vol. 28   2017.9

     More details

  208. Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2-4 gastric cancer. Reviewed Open Access

    Tanaka Y, Kanda M, Tanaka C, Kobayashi D, Mizuno A, Iwata N, Hayashi M, Niwa Y, Takami H, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association   Vol. 20 ( 4 ) page: 736 - 743   2017.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10120-016-0657-6

    Web of Science

    PubMed

  209. Stapling an extracorporeal Billroth-I anastomosis by the complete double stapling technique after laparoscopy-assisted distal gastrectomy. Reviewed

    Tanaka C, Fujiwara M, Kanda M, Murotani K, Iwata N, Hayashi M, Kobayashi D, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujii T, Kodera Y

    Asian journal of endoscopic surgery   Vol. 10 ( 2 ) page: 137 - 142   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/ases.12357

    Web of Science

    PubMed

  210. Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer. Reviewed

    Takeda S, Yamada S, Hattori N, Nakamura K, Tanaka H, Kajiyama H, Kanda M, Kobayashi D, Tanaka C, Fujii T, Fujiwara M, Mizuno M, Hori M, Kodera Y

    Annals of surgical oncology   Vol. 24 ( 5 ) page: 1188 - 1194   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-016-5759-1

    Web of Science

    PubMed

  211. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. Reviewed Open Access

    Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

    World journal of gastroenterology   Vol. 23 ( 14 ) page: 2519 - 2526   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3748/wjg.v23.i14.2519

    Open Access

    Web of Science

    PubMed

  212. The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902). Reviewed Open Access

    Nakayama G, Ishigure K, Yokoyama H, Uehara K, Kojima H, Ishiyama A, Hayashi N, Takano N, Hattori N, Kobayashi D, Tanaka C, Hayashi M, Kanda M, Yamada S, Sugimoto H, Koike M, Fujiwara M, Fujii T, Murotani K, Ando Y, Kodera Y

    BMC cancer   Vol. 17 ( 1 ) page: 243   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12885-017-3245-1

    Open Access

    Web of Science

    PubMed

  213. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. Reviewed Open Access

    Ninomiya G, Fujii T, Yamada S, Yabusaki N, Suzuki K, Iwata N, Kanda M, Hayashi M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    International journal of surgery (London, England)   Vol. 39   page: 45 - 51   2017.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ijsu.2017.01.075

    Web of Science

    PubMed

  214. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer. Reviewed Open Access

    Shimizu D, Kanda M, Tanaka H, Kobayashi D, Tanaka C, Hayashi M, Iwata N, Niwa Y, Takami H, Yamada S, Fujii T, Nakayama G, Fujiwara M, Kodera Y

    Scientific reports   Vol. 7   page: 42089   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/srep42089

    Open Access

    Web of Science

    PubMed

  215. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.

    Ninomiya, G; Fujii, T; Yamada, S; Asano, T; Takano, N; Takami, H; Iwata, N; Kanda, M; Niwa, Y; Hayashi, M; Kobayashi, D; Tanaka, C; Nakayama, G; Sugimoto, H; Fujiwara, M; Koike, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 35 ( 4 )   2017.2

  216. Clinical implication of inflammation-based prognostic score and perioperative nutrition control in pancreatic cancer.

    Takano, N; Yamada, S; Fujii, T; Tashiro, M; Tanaka, N; Morimoto, D; Ninomiya, G; Niwa, Y; Takami, H; Iwata, N; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 35 ( 4 )   2017.2

  217. Conversion surgery for unresectable gastric cancer following complete response of distant metastasis by systemic chemotherapy.

    Kobayashi, D; Kanda, M; Tanaka, C; Iwata, N; Hayashi, M; Yamada, S; Nakayama, G; Sugimoto, H; Koike, M; Fujii, T; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 35 ( 4 )   2017.2

  218. Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for gastric cancer.

    Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 35 ( 4 )   2017.2

  219. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy. Reviewed Open Access

    Shimizu D, Kanda M, Sugimoto H, Shibata M, Tanaka H, Takami H, Iwata N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y

    International journal of oncology   Vol. 50 ( 2 ) page: 381 - 386   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ijo.2017.3833

    Open Access

    Web of Science

    PubMed

  220. Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer. Reviewed Open Access

    Kanda M, Tanaka C, Kobayashi D, Mizuno A, Tanaka Y, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

    Annals of surgical oncology   Vol. 24 ( 2 ) page: 502 - 509   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-016-5544-1

    Open Access

    Web of Science

    PubMed

  221. The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer Open Access

    Kataoka, M; Kanda, M; Ishigure, K; Matsuoka, H; Sato, Y; Takahashi, T; Tanaka, C; Deguchi, T; Shibata, Y; Sato, M; Inagaki, H; Matsui, T; Kondo, A; Takano, N; Tanaka, H; Sakamoto, J; Oba, K; Kondo, K

    ANNALS OF SURGICAL ONCOLOGY   Vol. 24 ( 2 ) page: 546 - 553   2017.2

  222. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma. Reviewed Open Access

    Kurimoto K, Hayashi M, Guerrero-Preston R, Koike M, Kanda M, Hirabayashi S, Tanabe H, Takano N, Iwata N, Niwa Y, Takami H, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Fujii T, Fujiwara M, Kodera Y

    Epigenetics   Vol. 12 ( 10 ) page: 865 - 874   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/15592294.2017.1365207

    Web of Science

    PubMed

  223. Prognostic relevance of <i>SAMSN1</i> expression in gastric cancer. Reviewed Open Access

    Kanda M, Shimizu D, Sueoka S, Nomoto S, Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Oncology letters   Vol. 12 ( 6 ) page: 4708-4716   2016.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ol.2016.5233

    Open Access

    PubMed

  224. Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer. Reviewed Open Access

    Kanda M, Tanaka C, Kobayashi D, Tanaka H, Shimizu D, Shibata M, Takami H, Hayashi M, Iwata N, Niwa Y, Yamada S, Fujii T, Nakayama G, Fujiwara M, Kodera Y

    International journal of cancer   Vol. 139 ( 10 ) page: 2290-8   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ijc.30286

    PubMed

  225. Modified two-dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer. Reviewed Open Access

    Nakayama G, Fujii T, Murotani K, Uehara K, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Kanda M, Yamada S, Sugimoto H, Koike M, Fujiwara M, Ando Y, Kodera Y

    Cancer science   Vol. 107 ( 10 ) page: 1492-1498   2016.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cas.13023

    Open Access

    PubMed

  226. Predictive value of drain amylase content for peripancreatic inflammatory fluid collections after laparoscopic (assisted) distal gastrectomy. Reviewed

    Kanda M, Fujiwara M, Tanaka C, Kobayashi D, Iwata N, Mizuno A, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Kodera Y

    Surgical endoscopy   Vol. 30 ( 10 ) page: 4353-62   2016.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00464-016-4753-9

    PubMed

  227. Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer. Reviewed Open Access

    Kanda M, Shimizu D, Fujii T, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    International journal of oncology   Vol. 49 ( 3 ) page: 1195-202   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ijo.2016.3584

    Open Access

    PubMed

  228. Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer. Reviewed

    Kanda M, Shimizu D, Fujii T, Tanaka H, Tanaka Y, Ezaka K, Shibata M, Takami H, Hashimoto R, Sueoka S, Iwata N, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Annals of surgical oncology   Vol. 23 ( Suppl 4 ) page: 532-539   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-016-5375-0

    PubMed

  229. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Reviewed Open Access

    Kanda M, Mizuno A, Tanaka C, Kobayashi D, Fujiwara M, Iwata N, Hayashi M, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Takami H, Niwa Y, Murotani K, Kodera Y

    Medicine   Vol. 95 ( 24 ) page: e3781   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MD.0000000000003781

    Open Access

    PubMed

  230. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer. Reviewed Open Access

    Kanda M, Mizuno A, Fujii T, Shimoyama Y, Yamada S, Tanaka C, Kobayashi D, Koike M, Iwata N, Niwa Y, Hayashi M, Takami H, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y

    Annals of surgical oncology   Vol. 23 ( 6 ) page: 1934-40   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-016-5102-x

    Open Access

    PubMed

  231. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Reviewed Open Access

    Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Medicine   Vol. 95 ( 18 ) page: e3582   2016.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/MD.0000000000003582

    Open Access

    PubMed

  232. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer. Reviewed Open Access

    Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Oncotarget   Vol. 7 ( 12 ) page: 13667-79   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18632/oncotarget.7269

    Open Access

    PubMed

  233. S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model. Reviewed Open Access

    Suenaga M, Yamada S, Fujii T, Tanaka C, Kanda M, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Journal of surgical oncology   Vol. 113 ( 4 ) page: 413-9   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jso.24147

    PubMed

  234. NRAGE promotes the malignant phenotype of hepatocellular carcinoma. Reviewed Open Access

    Shimizu D, Kanda M, Sugimoto H, Sueoka S, Takami H, Ezaka K, Tanaka Y, Hashimoto R, Okamura Y, Iwata N, Tanaka C, Yamada S, Fujii T, Nakayama G, Koike M, Nomoto S, Fujiwara M, Kodera Y

    Oncology letters   Vol. 11 ( 3 ) page: 1847-1854   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ol.2016.4120

    Open Access

    PubMed

  235. Short-term outcomes after conventional transthoracic esophagectomy. Reviewed Open Access

    Niwa Y, Koike M, Hattori M, Iwata N, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y

    Nagoya journal of medical science   Vol. 78 ( 1 ) page: 69-78   2016.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.78.1.69

    Open Access

    PubMed

  236. Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer. Reviewed

    Mizuno A, Kanda M, Kobayashi D, Tanaka C, Iwata N, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Digestive surgery   Vol. 33 ( 2 ) page: 121-8   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000443219

    PubMed

  237. Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer. Reviewed

    Nakayama G, Tanaka C, Kodera Y

    Gastrointestinal tumors   Vol. 1 ( 1 ) page: 25-32   2013.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000354995

    PubMed

▼display all

Books 3

  1. 【早わかり縫合・吻合のすべて】(4章)術式別の縫合・吻合法 胃 噴門側胃切除術 ダブルトラクト再建での残胃-空腸吻合 腹腔鏡下

    田中 千恵, 清水 大, 小寺 泰弘( Role: Sole author)

    臨床外科   2020.10 

     More details

    Responsible for pages:145-148   Language:Japanese Book type:Scholarly book

  2. 【解剖学的変異を考慮した上部消化管手術】局所微細解剖からみた幽門下リンパ節郭清のコツ 腹腔鏡手術を中心に

    田中 千恵, 佐藤 敏, 神田 光郎, 清水 大, 小寺 泰弘( Role: Sole author)

    手術  2020.8 

     More details

    Responsible for pages:1339-1346   Language:Japanese Book type:Scholarly book

  3. 【若手外科医必携!-緊急手術の適応と術式】疾患別の対処法 胃十二指腸出血に対する緊急治療

    田中 千恵, 小寺 泰弘( Role: Sole author)

    臨床外科   2020.7 

     More details

    Responsible for pages:812-817   Language:Japanese Book type:Scholarly book

KAKENHI (Grants-in-Aid for Scientific Research) 18

  1. 手術修練機会におけるジェンダー格差の実証研究

    Grant number:25K15734  2025.4 - 2028.3

    科学研究費助成事業  基盤研究(C)

    河野 恵美子, 田中 千恵, 野村 幸世, 山本 博之

      More details

    Authorship:Coinvestigator(s) 

    外科における女性管理職は1%と極めて少ない。女性が指導的地位に就けない阻害要因を明らかにするために高難度手術ならびに最先端手術の手術執刀機会に着目した。先行研究では6術式(低・中・高難度手術各2術式)における男女別執刀数を検証し、高難度手術で著明な格差があることを実証した。これを受けて日本消化器外科学会は男女の均等な機会を約束する「函館宣言」を発出した。本研究では、6術式の執刀機会の追跡調査を実施するとともに、昇進に直結する最先端手術(腹腔鏡・ロボット支援手術)の男女別執刀機会について検証する。得られた知見から解決策を考察し、消化器外科学会のポジテイブアクションに繋げる。

  2. 食道癌転移の分子病態解明にもとづいたデュアル修飾型アンチセンス核酸医薬創出研究

    Grant number:24K02507  2024.4 - 2028.3

    科学研究費助成事業  基盤研究(B)

    神田 光郎, 中西 香企, 田中 千恵, 清水 大, 小比賀 聡, 笠原 勇矢

      More details

    Authorship:Coinvestigator(s) 

    食道癌は解剖学的・生物学的特徴から早期に転移をきたす予後不良な疾患である。なかでも難治な食道癌血行性転移の治療成績を改善するには、癌進展の精緻な病態解明に基づく新規分子標的治療薬の開発が望まれる。研究代表者らはTranscriptome解析において血行性遠隔転移を有する食道癌組織で有意な発現増加を認める分子群から標的分子としてAKR1B15とGDPD2を厳選した。本研究ではこれらの食道癌転移分子機構における機能を明らかにするとともに、医薬基盤・健康・栄養研究所創薬デザイン研究センターとの共同研究で革新的な効果を有する食道癌治療アンチセンス核酸医薬、およびその治療奏効度を予測するコンパニオン診断技術の開発を目指す。
    食道癌は解剖学的ならびに生物学的特徴から早期に転移をきたす予後不良な疾患である。なかでも難治な食道癌血行性転移の治療成績を改善するには、癌進展のさらに精緻な病態解明に基づく新規分子標的治療薬の開発が望まれる。研究代表者らはTranscriptome解析において血行性遠隔転移を有する食道癌組織で有意な発現増加を認める分子群から標的分子としてAKR1B15とGDPD2を厳選した。本研究ではこれらの食道癌転移分子機構における機能を明らかにするとともに、医薬基盤・健康・栄養研究所創薬デザイン研究センターとの共同研究で革新的な効果を有する食道癌治療アンチセンス核酸医薬、およびその治療奏効度を予測するコンパニオン診断技術の開発を目的としている。
    令和6年度の実績を以下に記す。
    アクセス効率を最大化するmRNA二次構造予測システムを用いてAKR1B15/GDPD2それぞれに対して候補配列をデザインした。アンチセンス核酸をCEM法によりトランスフェクションし、濃度依存性のノックダウン効率を評価した。一次候補配列は一定のノックダウン活性を示したが、濃度依存性の活性について再現性の高い結果が得られなかったため、対象食道扁平上皮癌細胞株が本実験系に適しているかをpositive controlとしてhMALTAに対するアンチセンス核酸のノックダウン活性を指標に評価し、問題がないことを確認した。ついで、二次候補配列をそれぞれ設計、合成した。これらからノックダウン活性をもとにAKR1B15 4配列、GDPD2 5配列の有望配列を選抜した。これらは全て、再現性をもって濃度依存性のノックダウン活性をを示した。現在、in vitroから機能解析実験へと進めている。
    一次候補配列は一定のノックダウン活性を示したが、濃度依存性の活性について再現性の高い結果が得られなかったため、以下の工程を要した。
    ・対象食道扁平上皮癌細胞株が本実験系に適しているかをpositive controlとしてhMALTAに対するアンチセンス核酸のノックダウン活性を指標に評価し、問題がないことを確認した。
    ・二次候補配列をそれぞれ設計、合成した。
    令和7年度は、以下を順次実施していく。
    腫瘍学的機能解析:AKR1B15とGDPD2がどのような分子生物学的機序によって食道癌転移に関与しているのかを明らかにする。ヒト食道扁平上皮癌細胞株を対象にして、AKR1B15/GDPD2ノックダウン前後での細胞増殖能、細胞接着能、浸潤能を評価する。また、Flow cytometryを用いてApoptosis細胞比率の変化および細胞周期の変化も調べる。細胞形態とスフェロイド形成能の変化、癌幹細胞性(ALDH発現細胞比率)の変化、食道癌のKey drugである5-FU、シスプラチン、パクリタキセル感受性の変化を調べる。レスキュー実験として無発現癌細胞株に強制発現を行い、細胞増殖能および浸潤能を評価する。
    シグナル解析:AKR1B15とGDPD2の細胞内pathwayへの干渉を知ることは未知な部分の多いAKR1B15/GDPD2の癌細胞での役割を紐解くこと、ひいては薬効メカニズムを明確にすることにつながる。AKR1B15/GDPD2ノックダウン前後の蛋白溶解液を対象に細胞内シグナル伝達経路のリン酸化部位を網羅的に比較解析する。
    臨床検体での発現解析:300症例の食道癌切除組織検体と非癌部食道組織を対象にAKR1B15/GDPD2 mRNA発現レベルを定量的PCR法で調べ、予後や転移形式との相関性を解析する。
    転移先臓器嗜好性のメカニズム解明:in vitroでは血行性転移の主たる転移先である肝臓と肺への嗜好性を評価するため、肝類洞内皮細胞(HSE細胞)とヒト肺微小血管内皮細胞(HPME細胞)への接着細胞比率のAKR1B15/GDPD2発現調節による変化を調べる。
    ・in vivoでは腹部食道への同所移植モデル(リンパ節転移を惹起)、尾静注による肺転移モデルでAKR1B15/GDPD2安定的ノックダウンの影響を比較評価する。

  3. Development of New Treatment for Cancer Using Dual-Modified Antisense Nucleic Acids Targeting Cell Adhesion Factors

    Grant number:23K21445  2024.4 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Kodera Yasuhiro

      More details

    Authorship:Coinvestigator(s) 

    In this study, we aimed to develop a new molecularly targeted therapy for gastric cancer by antisense nucleic acid medicine targeting cell adhesion factors. (1) Mechanism elucidation: WT/hetero/homo KO mice were observed to examine the biological effects of target cell adhesion factor loss, but there were no abnormal findings. Data on downstream intracellular signaling systems interfering with the target cell adhesion factor were obtained. (2) Evaluation of in vivo activity: Intraperitoneal administration of antisense nucleic acid to an Establish tumor (subcutaneous tumor) inhibited tumor growth. (3) Investigation of hepatotoxicity in mice: Sequence- and concentration-dependent hepatotoxicity was observed, both of which were reversible; In silico and microarray analysis were used to search for off-targets.

  4. Drug discovery based on elucidation of molecular mechanisms of esophageal cancer metastasis

    Grant number:21K19525  2021.7 - 2024.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Research (Exploratory)

    KODERA Yasuhiro

      More details

    Authorship:Coinvestigator(s) 

    The aim of this study was to identify the molecules responsible for hematogenous metastasis of esophageal cancer and to obtain data that will provide a basis for elucidating the molecular biological mechanisms of esophageal cancer metastasis, developing novel molecular targeted therapeutics, and developing companion diagnostics. Among the candidate molecules, we focused on NECAB2 based on functional analysis data. Knockdown of NECAB2 suppressed cell proliferative capacity via cell cycle regulation and induction of apoptosis in esophageal cancer cell lines. Furthermore, stable knockdown of NECAB2 using shRNA reduced cell invasiveness, adhesion to vascular endothelium, migration, and tumorigenesis in mouse subcutaneous xenograft models. Patients with high tissue NECAB2 expression had significantly shorter survival times and higher cumulative hematogenous metastasis rates.

  5. 細胞接着因子を標的とするデュアル修飾型アンチセンス核酸を用いた革新的癌治療薬創出

    Grant number:21H02984  2021.4 - 2025.3

    科学研究費助成事業  基盤研究(B)

    小寺 泰弘, 神田 光郎, 笠原 勇矢, 田中 千恵, 清水 大, 小比賀 聡

      More details

    Authorship:Coinvestigator(s) 

    本研究では、細胞接着因子を標的としたアンチセンス核酸医薬による新たな胃癌分子標的治療薬およびコンパニオン診断技術開発を目指して、以下を実施する。
    1) アンチセンス核酸スクリーニング、2) メカニズム解明(機能解析、シグナル解析、KOマウス解析、正常組織中発現解析)、3) in vitro活性評価(濃度依存性の活性、癌種横断的活性評価)、4) in vivo活性評価(皮下腫瘍モデル、同所移植モデルでの薬効評価)、5) 毒性評価とオフターゲット探索、6) コンパニオン診断(治療前生検、手術検体での免疫染色法による発現解析)
    本研究では、細胞接着因子を標的としたアンチセンス核酸医薬による新たな胃癌分子標的治療薬およびコンパニオン診断技術開発を目指して実験を進めている。令和3年度は、以下の進捗を得ている。
    1) アンチセンス核酸スクリーニング:アクセス効率を最大化するmRNAの二次構造予測システムを用いて候補配列をデザインし、29配列の中からノックダウン効率とin vitroでの胃癌細胞機能阻害効果から2つの有望配列を取得した。これら配列については、標的分子の発現レベルが低い癌細胞では抑制活性を示さず、オンターゲット活性であることも確認できている。
    2) メカニズム解明:同分子阻害の作用機序を調査している。2つの有望アンチセンス核酸配列を用いた標的細胞接着因子ノックダウンにより、胃癌細胞接着能および浸潤能が低下することを明らかにした。標的細胞接着因子無発現癌細胞株であるKATOIIIに対して標的分子の強制発現を行うと、胃癌細胞の増殖能が増強した。細胞内シグナル伝達系のリン酸化状態を網羅的に調査可能なPTM Scanを用いてアンチセンス核酸による標的細胞接着因子ノックダウン前後の細胞内シグナルの変化についてデータを得た。
    3) in vitro活性評価:選抜した有望アンチセンス核酸配列の濃度依存性なin vitro細胞増殖能阻害活性について、0.25nMから800nMの濃度域で検証した。このデータをもとに、翌年度以降のin vivo解析の投与量を設定していく。
    令和3年度は、序盤での有望配列スクリーニングが速やかに完了し、取得した2配列を用いた基礎データの構築が順調に進んだ。in vivo毒性テストの結果をみるまでは最終配列決定には至らないが、これら2配列を主軸に研究計画を進めていく。また、シグナル解析の第一歩としての網羅的リン酸化解析のデータを取得できたため、翌年度以降に再現性確認を含めて詳細に検討していく。標的細胞接着因子の阻害が生体に致命的な影響を与えないかを調べるためのノックアウトマウスの合成にも着手した。
    研究計画は順調に推移しており、当初の計画に沿って令和4年度も研究を進めていく。メカニズム解明(担当:研究代表者 小寺、研究分担者 神田、清水)として、癌細胞の転移能や薬剤抵抗性に重要である癌幹細胞性について調査する。アンチセンス核酸による標的分子ノックダウン前後でのスフェロイド形成能について調べる。また、胃癌を含むさまざまな固形癌におけるkey drugである5-FUおよびシスプラチン感受性への影響についても解析する。令和3年度にPTM Scanで抽出された候補シグナル系に着目してwestern blotting法で詳細に検討する。ゲノム編集技術を用いたノックアウトマウスを樹立する。
    ついで、in vitro活性評価(担当:研究分担者 神田)も拡大する。選抜配列を用いて、癌種横断的(食道癌、膵癌、大腸癌、肝癌、乳癌)に細胞株に対する細胞増殖阻害能をin vitroで調べる。in vivo活性評価(担当:研究代表者 小寺、研究分担者 清水)として、有望2配列のマウス皮下腫瘍モデルに対するアンチセンス核酸腹腔内投与での造腫瘍能抑制効果を評価する。

  6. Risk assessment and evaluation of intervention for postoperative functional decline in older patients received gastrointestinal cancer surgery

    Grant number:21K11620  2021.4 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Tanaka Chie

      More details

    Authorship:Principal investigator 

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Geriatric assessments were conducted during the perioperative period, and it was confirmed that the postoperative complications, postoperative delirium, open surgery, and preoperative sarcopenia were associated with the decline in postoperative activities of daily living (ADL). Furthermore, the effect of rehabilitation intervention in ADL was evaluated in patients with sarcopenia preoperatively. As a result, there was a tendency toward less decline in basic activities of daily living (BADL) in the intervention group compared to the non-intervention group. Subsequently, we explored potential biomarkers associated with the decline in BADL. Although proteomic analysis identified candidate proteins potentially associated with postoperative BADL decline, the trends observed in the initial proteomic screening was not confirmed in the validation studies using ELISA.

  7. Development of amido-bridged nucleic acid-modified antisense oligonucleotides to treat gastrointestinal malignancies

    Grant number:20K21629  2020.7 - 2022.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Research (Exploratory)

    KANDA Mitsuro

      More details

    Authorship:Coinvestigator(s) 

    We aimed to develop novel therapeutic agents using antisense nucleic acid drugs for metastatic or recurrent gastrointestinal cancers. Through a transcriptome analysis, CSRNP3, CPLX1, and RNFT2 were selected as candidate molecules controlling cancer metastasis. The antisense nucleic acids designed with the secondary structure prediction system showed an inhibitory effects of cell proliferative potential in a variety type of cancers. Antisense nucleic acid against CSRNP3 inhibited tumor progression in mouse peritoneal metastasis models. Moreover, knockdown of CSRNP3 enhanced the antitumor effect of cisplatin in mouse subcutaneous tumor models. Tissue expression levels were correlated with survival and metastatic recurrence rates in patients with gastric cancer.

  8. Development of monoclonal antibody targeting CHRNB2 to treat gastric cancer

    Grant number:20H03750  2020.4 - 2024.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    KANDA Mitsuro

      More details

    Authorship:Coinvestigator(s) 

    The aim of this study was to discover antibody drugs that inhibit Cholinergic Receptor Nicotinic Beta 2 Subunit (CHRNB2), develop antibody-drug conjugates, clarify the mechanism of action, and develop companion diagnostics. No abnormalities were observed in CHRNB2-deficient mice. The antibody specifically bounds to CHRNB2 protein on the cell membrane. The birecore analysis revealed that KD value of the monoclonal antibody was 5.0 nM. CHRNB2 antibody-DM1 complex showed in vitro and in vivo inhibitory effect on cell proliferation ability of gastric cancer cells beyond that of the naked monoclonal antibodies. Immunostaining of CHRNB2 protein in the clinical gastric cancer tissues is found to be usable for selection of patients who have CHRNB2 expression.

  9. Multi-omics analysis to identify predictors for treatment efficacy of perioperative chemotherapy in advanced gastric cancer

    Grant number:19K22653  2019.6 - 2021.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Research (Exploratory)

    KODERA Yasuhiro

      More details

    Authorship:Coinvestigator(s) 

    As a pivotal clinical trial for development of treatment strategy for clinical stage III gastric cancer, a multicenter, randomized phase III clinical trial to confirm the superiority of addition of preoperative adjuvant chemotherapy with S-1 + oxaliplatin (SOX) over standard treatment is ongoing. If the efficacy of chemotherapy can be predicted before decision making of treatment, physicians can select the most appropriate treatment method for each patient, which will have great significance not only in terms of treatment effect but also in terms of medical economics. In this study, we performed a multi-omics analysis and identified candidate markers for the efficacy of preoperative SOX therapy in plasma samples (protein and microRNA). Moreover, we confirmed the feasibility of the Cancer Panel using endoacopic biopsy FFPE samples. The results of this study will greatly enhance the quality of a future biomarker study.

  10. Development of therapeutic antibody and companion diagnostic technology for esophageal cancer

    Grant number:19K09140  2019.4 - 2022.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    KOIKE Masahiko

      More details

    Authorship:Coinvestigator(s) 

    Since patients with esophageal cancer have a poor prognosis, identification of novel esophageal cancer-related molecules is desirable. In this study, we focused on NPTXR, a receptor that is frequently upregulated in esophageal squamous cell carcinoma. shRNA-mediated functional analysis of NPTXR revealed that NPTXR regulates the proliferative potential, invasive potential, and 5-FU resistance of esophageal cancer cells. It was demonstrated that NPTXR mediated malignant phenotypes of esophageal cancer cells primarily through Akt-mTOR signaling. Anti-NPTXR antibody inhibited the growth of esophageal squamous cell carcinoma cell lines in vitro. NPTXR expression levels in esophageal cancer tissues was clearly distinguishable by immunohistochemical staining and correlated with postoperative recurrences and metastasis.

  11. 介入による消化器癌周術期高齢者機能の改善と機能低下に影響するバイオマーカー探索

    Grant number:17K01841  2017.4 - 2021.3

    田中 千恵

      More details

    Authorship:Principal investigator 

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    一昨年の解析結果をまとめると、胃癌に対する胃切除を施行した症例において、自立度、錯乱、認知機能は術前の平均スコアと比較して、退院時の平均スコアのみでなく術後6ヶ月もスコアは低下していなかった。さらに退院時に自立度が低下した症例を対象として低下の予測因子を調査したところ、年齢、性別、胃全摘術、せん妄は関連を認めなかった。しかし、術後合併症の有無(p=0.0326)が自立度低下の予測因子としてあげられた。術前と比較した退院時の認知機能低下は40例中7例(18例)に認められた。
    本研究においてMMSEやCDR-Jといった認知機能の評価は専門医である老年科医師により行われている。現実問題として、これらの評価を周術期に外科医が行うことは困難である上に、専門医による認知機能の評価がどの病院でも常時可能であるとは言えない。我々は認知機能低下症例におけるバイオマーカーを含めた予測因子の探索を行った。
    まずは術前と比較して退院時にMMSEスコアが低下した症例を対象に、臨床病理学的な予測因子の有無を調査したところ、術後せん妄を認めた症例(p=0.1890)、術後在院日数が本研究の平均値である19日を超える症例(p=0.0751)、Clavien-Dindo分類II以上の術後合併症を発症した症例(p=0.0498)であった。以上より、術後合併症を発生した症例はMMSEスコアが有意に低下していたことがわかった。術前IL-6・アディポネクチン・レジスチンの値と術後MMSE低下に明らかな関連は認めなかった。術後CDR-Jスコアの悪化と上記の各因子との間に関連は認めなかった。
    以上より、認知機能の低下と関連するバイオマーカーは見いだせていないが、術後合併症の発生は、自立度のみでなく認知機能の低下に影響する可能性があると考えられた。
    症例集積に時間を要した。しかし、昨年度で高齢者機能評価の測定とバイオマーカー測定は概ね終了した。今後は成果報告を行う。
    成果報告を行うために1年延長した。
    今後は学会、英語論文での成果報告を進めたい。
    さらに、サルコペニアやサルコペニア症例に対する手術の影響などより詳細な解析を進める。バイオマーカー探索も続ける予定である。

  12. Molecule target for treatment and companion diagnostic tool of peritoneal dissemination in gastric cancer

    Grant number:17H04281  2017.4 - 2020.3

    KODERA Yasuhiro

      More details

    Authorship:Coinvestigator(s) 

    Peritoneal metastasis is a frequent cause of death in patients with gastric cancer. The pathophysiology and thus targets for treatment are unknown. Synaptotagmin XIII (SYT13) was expressed in patients with peritoneal recurrence of gastric cancer. Inhibition of SYT13 expression in gastric cancer cell lines was associated with decreased invasion and migration ability of the cells. In vivo experiments using a mouse xenograft model of gastric cancer showed that intraperitoneal administration of SYT13-specific small interfering RNA or antibodies significantly inhibited the growth of peritoneal nodules and prolonged survival. SYT13 expression in primary gastric cancer tissues or ascites fluids had diagnostic potential both in the detection and prediction of peritoneal metastasis of gastric cancer. SYT13 may also be a promising target for the treatment of peritoneal metastasis of gastric cancer.

  13. The diagnostic performance and mechanisms of the release into the circulation of novel serum biomarkers for gastric cancer

    Grant number:17K10581  2017.4 - 2020.3

    KANDA Mitsuro

      More details

    Authorship:Coinvestigator(s) 

    Development of high-performance serum biomarkers will likely improve treatment outcomes of patients with gastric cancer (GC). We conducted a prospective multicenter observational study aimed at validating the diagnostic performance of these potential markers. We analyzed serum levels before and after surgery of the three potential biomarkers in patients with GC and healthy volunteers. Quantification of serum and GC tissue levels was performed using an ELISA. Area under the curve values that discriminated patients with GC from healthy controls were-0.7058, 0.6188, and 0.5031 for ANOS1, DPYSL3, and MAGED2, respectively. Serum ANOS1 levels were significantly elevated in patients with stage I GC compared with those of healthy controls and decreased after resection of primary GC lesions. The combination of serum ANOS1 and DPYSL3 levels increased the AUC value that discriminated patients with GC from healthy controls.

  14. 介入による消化器癌周術期高齢者機能の改善と機能低下に影響するバイオマーカー探索

    Grant number:17K01841  2017.4 - 2019.3

    基盤研究(C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

  15. Novel surgical education system improved by instructional design

    Grant number:16K08868  2016.4 - 2020.3

    Fujiwara Michitaka

      More details

    Authorship:Coinvestigator(s) 

    In this study we create an outcome-based training course for endoscopic surgery.
    Competences required for each operative procedure were analyzed and subdivided, and the unit was defined as “module”. At first the tasks of conventional dry laboratory were applied to these modules, and the new training systems were constructed. Using the method of instructional design, the structure of modules was modified and a module was rebuilt while performing surgical seminars. A course for laparoscopic cholecystectomy that most surgeon initially learn was designed as a model of procedure course. New box trainer related to many modules was developed as a module improvement.

  16. 内視鏡手術シミュレーション訓練の新しい統合的基本タスク

    Grant number:26460594  2014.5 - 2016.3

    基盤研究(C)

      More details

    Authorship:Principal investigator 

    Grant amount:\5070000 ( Direct Cost: \3900000 、 Indirect Cost:\1170000 )

  17. Novel integrated simulation task for laparoscopic surgery training

    Grant number:26460594  2014.4 - 2018.3

    Tanaka Chie

      More details

    Authorship:Principal investigator 

    Grant amount:\5070000 ( Direct Cost: \3900000 、 Indirect Cost:\1170000 )

    Regarding the training of endoscopic surgery, we usually use animal laboratory training as intermediate task between simulation training of basic technique and on-the-job training during actual operation, while there are many problems in the animal laboratory training as well known.
    In this study, we aimed to create new tasks to replace animal trainings. We developed the perivascular dissection program and the intestinal anastomosis program as the integrated tasks combining basic procedures. We created various phantoms of intestinal tract and box trainers. We also used VR module for the perivascular dissection program. Evaluation of both program was based on a checklist of a supervising doctor and a trainee and the results were fed back to the trainee in the briefing. We actually perform these programs in our simulation center, improving the systems.

  18. 手術中の医療者の疲労,ストレスの客観的評価,リアルタイム測定法の研究

    2013.4 - 2015.3

    科学研究費補助金  基盤研究(B)

      More details

    Authorship:Coinvestigator(s) 

▼display all